Clinical Trials: Evidence and Unanswered Questions – Hyperlipidaemia

Publisher： Karger

E-ISSN： 1421-9786|16|3|25-32

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.16, Iss.3, 2003-06, pp. : 25-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials: Evidence and Unanswered Questions – Hypertension

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Treatment of isolated systolic hypertension in the elderly: evidence from three clinical trials

By Kosmulski M.   Eriksson P.   Brancewicz C.   Rosenholm J.B.   Staessen J.A.   Gasowski J.   Wang J.G.  

European Journal of Internal Medicine, Vol. 10, Iss. 2, 1999-07 ,pp. : 82-87

Elsevier

Access to resources Recommend Favorite

The Limitations of Transferring Evidence from Clinical Trials to the Care of Individual Patients

By Alderman Michael H.  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Diabetic Retinopathy: Evidence from Clinical Trials and Perspectives

By  

Current Diabetes Reviews, Vol. 7, Iss. 3, 2011-05 ,pp. : 190-200

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of olmesartan on oxidative stress in hypertensive patients. Mechanistic support to clinical trials derived evidence

By Calò Lorenzo A.   Maso Lucia Dal   Caielli Paola   Pagnin Elisa   Fusaro Maria   Davis Paul A.   Pessina Achille C.  

Blood Pressure, Vol. 20, Iss. 6, 2011-12 ,pp. : 376-382

Informa Healthcare

Access to resources Recommend Favorite